Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor).
Transfer factor derived from lymphocytes of donors with strong cellular immunity against beryllium was intradermally or subcutaneously injected into unprimed or subclinically primed human recipients who were patch test-negative. These recipients were challenged with beryllium at weekly intervals thereafter. Subjects who had been subclinically primed and received transfer factor either intradermally or subcutaneously showed transient patch test reactivity to the challenge. Subjects who received transfer factor but were not primed and subjects who had been primed but did not receive transfer factor showed no such conversion. This is the first demonstration of transfer of contact sensitivity in man using transfer factor, and it suggests that subclinical priming is necessary for such transfers.
D001608:Beryllium / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D000939:Epitopes; D006099:Granuloma / Q000209:etiology; D007111:Immunity, Cellular; D012882:Skin Tests; D014165:Transfer Factor / Q000502:physiology*
D000939:Epitopes; D014165:Transfer Factor; D001608:Beryllium